RecruitingNot Applicable

The Role of hs Troponin I and NT-proBNP in Predicting Atrial Fibrillation in Patients With Permanent Pacemakers

Vietnam300 participantsStarted 2023-12-01

Plain-language summary

The goal of this clinical trial is to answer the research question whether hs Troponin I and NT-proBNP have a role in detecting atrial fibrillation in patients with pacemakers. Objectives of the study: 1. To survey some risk factors for atrial fibrillation in patients with permanent pacemakers. 2. To determine the role of hs Troponin I and NT-proBNP in predicting new-onset atrial fibrillation within follow-up time. 3. To build a model to predict the prognosis of atrial fibrillation based on the detected subclinical markers related to atrial fibrillation and classic cardiovascular risk factors.

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Patient is an adult (≥ 18 years old or older) * There is indication for permanent pacemaker placement and patient agreement to permanent pacemaker placement * Patient agrees to participate in the study Exclusion Criteria: * Patients had a diagnosis of atrial fibrillation in their past history or atrial fibrillation is discovered at the time of participating in the study * Severe patients, at risk of death * Pregnant * The patient is indicated for surgery * Patients with eGFR ≤ 30 mL/min/1.73m2 * The patient has a serious infection

What they're measuring

Atrial fibrillation

Timeframe: through study completion, an average of 2 year

Trial details

NCT IDNCT06174506

SponsorUniversity of Medicine and Pharmacy at Ho Chi Minh City

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2026-09-30

Contact for this trial

Linh HK Duong, Master, MD

+ 84 0366698048 khanhlinh175@gmail.com

View on ClinicalTrials.gov More Atrial Fibrillation trials